Breathlessness with Pleural Effusion: What Do We Know?

被引:5
|
作者
Muruganandan, Sanjeevan [1 ,2 ,8 ]
Mishra, Eleanor [3 ,4 ]
Singh, Bhajan [5 ,6 ,7 ]
机构
[1] Northern Hosp, Dept Resp Med, Melbourne, Australia
[2] Univ Melbourne, Sch Med, Hlth Sci, Dent, Melbourne, Australia
[3] Univ East Anglia, Norwice Med Sch, Norwich, Norfolk, England
[4] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Norwice Med Sch, Norwich, Norfolk, England
[5] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep Med, Perth, Australia
[6] Univ Western Australia, Sch Human Sci, Perth, Australia
[7] West Australian Sleep Disorders Res Inst, Perth, Australia
[8] Northern Hlth, Dept Resp Med, 230 Cooper St, Epping, Vic 3076, Australia
关键词
dyspnea; breathlessness; pleural effusion; ultrasonography; VAS; diaphragm; GAS-EXCHANGE; LUNG-FUNCTION; HEMIDIAPHRAGM SECONDARY; DIAPHRAGMATIC MOTION; PULMONARY MECHANICS; TALC PLEURODESIS; THORACENTESIS; DYSPNEA; ULTRASOUND; REPRODUCIBILITY;
D O I
10.1055/s-0043-1769098
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Breathlessness is the most common symptom in individuals with pleural effusion and is often disabling. The pathophysiology of breathlessness associated with pleural effusion is complex. The severity of breathlessness correlates weakly with the size of the effusion. Improvements in ventilatory capacity following pleural drainage are small and correlate poorly with the volume of fluid drained and improvements in breathlessness. Impaired hemidiaphragm function and a compensatory increase in respiratory drive to maintain ventilation appear to be an important mechanism of breathlessness associated with pleural effusion. Thoracocentesis reduces diaphragm distortion and improves its movement; these changes appear to reduce respiratory drive and associated breathlessness by improving the neuromechanical efficiency of the diaphragm.
引用
收藏
页码:502 / 508
页数:7
相关论文
共 50 条
  • [41] WHAT DO WE KNOW ABOUT SHEAR WAVE DISPERSION IN NORMAL AND STEATOTIC LIVERS?
    Parker, Kevin J.
    Partin, Alexander
    Rubens, Deborah J.
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2015, 41 (05) : 1481 - 1487
  • [42] BPD- WHAT DO WE KNOW ABOUT THE LONG-TERM OUTCOME?
    Vrijlandt, Elianne
    PEDIATRIC PULMONOLOGY, 2014, 49 : S28 - S29
  • [43] What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics?
    van Dorst, Josie M.
    Tam, Rachel Y.
    Ooi, Chee Y.
    NUTRIENTS, 2022, 14 (03)
  • [44] Pleural effusion: Diagnosis and management
    Pastre, J.
    Roussel, S.
    Biet, D. Israel
    Sanchez, O.
    REVUE DE MEDECINE INTERNE, 2015, 36 (04): : 248 - 255
  • [45] Sonography of malignant pleural effusion
    Gorg, C
    Restrepo, I
    Schwerk, WB
    EUROPEAN RADIOLOGY, 1997, 7 (08) : 1195 - 1198
  • [46] The role of ultrasound in diagnosing rheumatoid arthritis, what do we know? An updated review
    Philip Rask Lage-Hansen
    Hanne Lindegaard
    Stavros Chrysidis
    Lene Terslev
    Rheumatology International, 2017, 37 : 179 - 187
  • [47] Activity limitation and exertional dyspnea in adult asthmatic patients: What do we know?
    Vermeulen, Francois
    Garcia, Gilles
    Ninane, Vincent
    Laveneziana, Pierantonio
    RESPIRATORY MEDICINE, 2016, 117 : 122 - 130
  • [48] The role of ultrasound in diagnosing rheumatoid arthritis, what do we know? An updated review
    Lage-Hansen, Philip Rask
    Lindegaard, Hanne
    Chrysidis, Stavros
    Terslev, Lene
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (02) : 179 - 187
  • [49] Diagnostic approach in pleural effusion
    Oyonarte, W. Maite
    REVISTA MEDICA CLINICA LAS CONDES, 2024, 35 (3-4): : 299 - 308
  • [50] Use of lung ultrasound for the diagnosis and treatment of pleural effusion
    Shao, R. J.
    DU, M. J.
    Xie, J. T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (23) : 8771 - 8776